Women's Health, Pregnancy, and the U.S. Food and Drug Administration
- 1 January 2014
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 123 (1), 161-165
- https://doi.org/10.1097/aog.0000000000000063
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal riskPharmacoepidemiology and Drug Safety, 2013
- Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001–2007: a population-based study of 585,615 deliveriesArchives of Women's Mental Health, 2013
- Prevalence, Trends, and Patterns of Use of Antidiabetic Medications Among Pregnant Women, 2001-2007Obstetrics & Gynecology, 2013
- Trends in the Use of Antiepileptic Drugs among Pregnant Women in the US, 2001–2007: A Medication Exposure in Pregnancy Risk Evaluation Program StudyPaediatric and Perinatal Epidemiology, 2012
- Lactation Safety Recommendations and Reliability Compared in 10 Medication ResourcesAnnals of Pharmacotherapy, 2007
- Cessation of asthma medication in early pregnancyAmerican Journal of Obstetrics and Gynecology, 2006
- Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant TreatmentJAMA, 2006
- A screening study of antidepressant treatment rates and mood symptoms in pregnancyArchives of Women's Mental Health, 2005
- Pregnancy exposure registries.Drug Safety, 2004
- Adenocarcinoma of the VaginaNew England Journal of Medicine, 1971